Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below. Just click on the icons to get to the download page.
Or continue login with
Novartis's Sandoz division will not profit from 15 generic drugs it is making available to devel...
Swiss drugmaker Novartis is halting its trial of malaria drug hydroxychloroquine (HCQ) against COVID...
Novartis has won the go-ahead from the US Food and Drug Administration to conduct a randomized trial...
Swiss drugmaker Novartis on Friday won US approval for its gene therapy Zolgensma for spinal mu...
US regulators have approved a new drug as an initial treatment for postmenopausal women with a type ...